BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21802592)

  • 1. Hidden extras: the projected impact of colorectal cancer screening and the burden of procedures on screening centers.
    Dunne C; Harewood GC
    Gastrointest Endosc; 2011 Aug; 74(2):448-9. PubMed ID: 21802592
    [No Abstract]   [Full Text] [Related]  

  • 2. Capacity for colorectal cancer screening by colonoscopy, Montana, 2008.
    Ballew C; Lloyd BG; Miller SH
    Am J Prev Med; 2009 Apr; 36(4):329-32. PubMed ID: 19285198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.
    Ladabaum U; Song K
    Gastroenterology; 2005 Oct; 129(4):1151-62. PubMed ID: 16230069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
    Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB
    Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.
    Zarchy T
    Gastroenterology; 2006 Mar; 130(3):1012; author reply 1012. PubMed ID: 16530546
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorectal cancer in India: present status.
    Makharia GK
    Trop Gastroenterol; 2006; 27(4):139-41. PubMed ID: 17542289
    [No Abstract]   [Full Text] [Related]  

  • 8. Colorectal cancer screening and surveillance: current standards and future trends.
    Martinez SR; Young SE; Hoedema RE; Foshag LJ; Bilchik AJ
    Ann Surg Oncol; 2006 Jun; 13(6):768-75. PubMed ID: 16604473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Colorectal Cancer Control Program: partnering to increase population level screening.
    Joseph DA; DeGroff AS; Hayes NS; Wong FL; Plescia M
    Gastrointest Endosc; 2011 Mar; 73(3):429-34. PubMed ID: 21353839
    [No Abstract]   [Full Text] [Related]  

  • 10. Colorectal cancer: screening and surveillance for high-risk individuals.
    Ferrández A; DiSario JA
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):851-62. PubMed ID: 14686707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening and surveillance: the present and the future.
    Rex DK
    Rev Gastroenterol Disord; 2001; 1(1):18-31. PubMed ID: 12120116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance after positive and negative colonoscopy examinations: issues, yields, and use.
    Schoen RE
    Am J Gastroenterol; 2003 Jun; 98(6):1237-46. PubMed ID: 12818263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer: does it all start with aberrant crypt foci?
    Rasheed S; Rigas B
    Gastrointest Endosc; 2008 Jun; 67(7):1103-5. PubMed ID: 18513552
    [No Abstract]   [Full Text] [Related]  

  • 14. Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia.
    Lane JM; Chow E; Young GP; Good N; Smith A; Bull J; Sandford J; Morcom J; Bampton PA; Cole SR
    Gastroenterology; 2010 Dec; 139(6):1918-26. PubMed ID: 20723544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of colorectal adenomas in patients with a family history of colorectal cancer: some implications for screening programmes.
    Novis B; Spitz B
    Gastrointest Endosc; 1997 Jun; 45(6):543-4. PubMed ID: 9199927
    [No Abstract]   [Full Text] [Related]  

  • 16. Colorectal cancer screening: health impact and cost effectiveness.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):80-9. PubMed ID: 16777546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy.
    Avidan B; Sonnenberg A; Schnell TG; Leya J; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Jun; 97(6):1524-9. PubMed ID: 12094877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the identification of high risk groups increase the effectiveness of colon cancer screening programmes?
    Vasen HF
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S41-2. PubMed ID: 18368642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.